DWA
CLPT icon

Dorsey Wright & Associates’s ClearPoint Neuro CLPT Stock Holding History

Dorsey Wright & Associates’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,069
Closed -$64.9K – 308
2021
Q1 		$64.9K Buy
3,069
+1,761
+135% +$37.7K 0.76% 27
2020
Q4 		$21K Buy
+1,308
New +$11.7K ﹤0.01% 178

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CCM
Conway Capital Management Burbank, California $214M AUM 22.99% 1-Year Est. Return

Dorsey Wright & Associates's CLPT Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of ClearPoint Neuro (CLPT) in Q2 2021, closing a stake of 3,069 shares — an estimated $64.9K sold.

Dorsey Wright & Associates first reported a position in CLPT in Q4 2020 and held it in 2 quarters. The position peaked at $64.9K in Q1 2021. 76 funds tracked by Wall St. Rank hold CLPT as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining ClearPoint Neuro position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,069 ClearPoint Neuro shares in Q2 2021, an estimated $64.9K.
  • Dorsey Wright & Associates first reported a position in ClearPoint Neuro in Q4 2020 and held it in 2 quarters.
  • Dorsey Wright & Associates's ClearPoint Neuro position peaked at $64.9K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.